Kenai Therapeutics

Cambridge, MA · Founded 2022 · Privately Held (backing)

Operator of a biotechnology company intended to cure neurological disease. Kenai Therapeutics is based in Cambridge, MA and was founded in 2022. Its last known valuation is $110 million. It has raised $86.8 million.

Last price · $/share
—
Implied valuation
$110.0M
Total raised
$86.8M
Last round
—

Who backs Kenai Therapeutics?

6 investors
InvestorType
Euclidean CapitalFamily office
Alaska Permanent FundOther
California Institute for Regenerative Medicine—
Cure Ventures—
Saisei Ventures—
The Column Group—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Kenai Therapeutics investors

6 investors are on record for Kenai Therapeutics, including Euclidean Capital, Alaska Permanent Fund, California Institute for Regenerative Medicine and Cure Ventures.

Free account
More of Kenai Therapeutics with a free account
  • ·Watch Kenai Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 6 firms already write checks for companies like Kenai Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View